[Ocular hypertension in children treated with brimonidine 0.2%. A clinical study].
To evaluate the safety and efficacy of topical brimonidine 0.2% use in children. A descriptive study of twelve successive children (21 eyes) who needed topical treatment of intraocular hypertension, and where the use of b-blockers was contraindicated. During treatment we observed an average decrease of IOP of 5 SD 1.8 mmHg (21% of basal IOP), but found more common local symptoms, with stinging being complained of in 52.4% of cases. Somnolence was also complained of in two cases.